Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
The Treatment of Advanced Thyroid Cancer Using Pemetrexed Monotherapy or with Platinum-Based Chemotherapy.
Journal: Thyroid : official journal of the American Thyroid Association
Published: July 29, 2026
Targeting of MEK and Autophagy in Pancreatic Adenocarcinoma and Analysis of Treatment Sensitivity in Preclinical and Clinical Models: MEKiAUTO.
Journal: JCO precision oncology
Published: June 12, 2026
Efficacy and Toxicity of Triweekly Versus Weekly Cisplatin in Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma.
Journal: International journal of cancer
Published: May 25, 2026
A Phase 2 Basket Trial of Ado-Trastuzumab Emtansine for Patients with HER2 Amplified Cancers: A Non-Randomized Clinical Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 24, 2026
Transoral Robotic Surgery-Based Treatment Versus Definitive Chemoradiation for Oropharyngeal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
Journal: Head & neck
Published: February 11, 2026
Nonoperative Management of Locally Advanced Resectable Cutaneous Squamous Cell Cancer of the Head and Neck with PD-1 Blockade.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 13, 2026
Updated Estimates of Patients With Oropharyngeal Cancer in the US.
Journal: JAMA network open
Published: October 24, 2025
Optimal post-treatment surveillance strategy for human papillomavirus-positive oropharyngeal cancer.
Optimal post-treatment surveillance strategy for human papillomavirus-positive oropharyngeal cancer.
Journal: Cell reports. Medicine
Published: August 07, 2025
Intensity-modulated proton therapy vs intensity-modulated radiotherapy in nasopharyngeal carcinoma: a case-control study.
Journal: Lancet regional health. Americas
Published: July 19, 2025
Evaluation of progression-free status at 24 months as a surrogate endpoint for overall survival in patients with human papillomavirus-positive oropharyngeal cancer: a retrospective cohort study.
Journal: The Lancet. Oncology
Published: July 16, 2025
Last Updated: 09/26/2026